Creating a new way to treat peanut allergies using microneedles
Scale-up manufacturing of microneedle stamp for peanut allergen immunotherapy
['FUNDING_OTHER'] · MOONLIGHT THERAPEUTICS, INC. · NIH-11084470
This study is testing a new way to help kids with peanut allergies feel safer by using tiny microneedles to deliver peanut allergens into their skin, which could help them build up a tolerance and reduce the chances of serious allergic reactions.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MOONLIGHT THERAPEUTICS, INC. (nih funded) |
| Locations | 1 site (Marietta, UNITED STATES) |
| Trial ID | NIH-11084470 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a microneedle stamp that can deliver peanut allergens into the skin to help desensitize children with peanut allergies. The approach aims to provide a targeted and efficient method for immunotherapy, which could significantly reduce the risk of severe allergic reactions. By using microneedles that penetrate only the top layers of skin, the treatment is designed to be quick and minimally invasive. The goal is to improve the quality of life for children with peanut allergies and provide peace of mind for their families.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who have a diagnosed peanut allergy.
Not a fit: Patients who do not have a peanut allergy or are older than 11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new, effective treatment for peanut allergies, reducing the risk of life-threatening reactions.
How similar studies have performed: Other research has shown promise in using microneedle technology for allergen immunotherapy, indicating potential for success in this approach.
Where this research is happening
Marietta, UNITED STATES
- MOONLIGHT THERAPEUTICS, INC. — Marietta, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PATEL, SAMIRKUMAR — MOONLIGHT THERAPEUTICS, INC.
- Study coordinator: PATEL, SAMIRKUMAR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.